Phase II Single-Arm Study of ON 01910.Na by 2-hr Infusion in Patients With Recurring Platinum-Resistant Ovarian Cancer.

Trial Profile

Phase II Single-Arm Study of ON 01910.Na by 2-hr Infusion in Patients With Recurring Platinum-Resistant Ovarian Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Jul 2017

At a glance

  • Drugs Rigosertib (Primary)
  • Indications Ovarian cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Dec 2011 Actual patient number is 1 as reported by ClinicalTrials.gov.
    • 13 Jul 2011 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
    • 13 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top